AVITA Medical, Inc.
AVHHL
$0.8125
-$0.1875-18.75%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 38.32% | 41.35% | 28.14% | 32.24% | 32.53% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 38.32% | 41.35% | 28.14% | 32.24% | 32.53% |
| Cost of Revenue | 56.27% | 36.56% | 16.89% | 17.45% | 11.63% |
| Gross Profit | 35.42% | 42.20% | 30.20% | 35.09% | 36.67% |
| SG&A Expenses | 10.15% | 25.73% | 39.28% | 48.57% | 50.82% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | 97.54% | 91.22% |
| Total Operating Expenses | 12.04% | 22.09% | 30.23% | 45.62% | 47.53% |
| Operating Income | 14.10% | -2.54% | -32.70% | -62.36% | -66.26% |
| Income Before Tax | -3.67% | -27.40% | -74.97% | -70.50% | -63.23% |
| Income Tax Expenses | -96.51% | -51.52% | -18.18% | -39.74% | 21.13% |
| Earnings from Continuing Operations | -3.50% | -27.28% | -74.80% | -70.25% | -63.13% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.50% | -27.28% | -74.80% | -70.25% | -63.13% |
| EBIT | 14.10% | -2.54% | -32.70% | -62.36% | -66.26% |
| EBITDA | 16.23% | -1.07% | -32.01% | -62.44% | -66.74% |
| EPS Basic | -1.31% | -24.60% | -71.18% | -66.94% | -60.25% |
| Normalized Basic EPS | 12.51% | -5.64% | -40.80% | -81.75% | -79.52% |
| EPS Diluted | -1.31% | -24.60% | -70.66% | -66.42% | -59.70% |
| Normalized Diluted EPS | 12.51% | -5.64% | -40.80% | -81.75% | -79.52% |
| Average Basic Shares Outstanding | 2.42% | 2.35% | 2.18% | 1.92% | 1.74% |
| Average Diluted Shares Outstanding | 2.42% | 2.35% | 2.18% | 1.92% | 1.74% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |